Results 71 to 80 of about 1,664 (165)
Comparative efficacy of mono- and combined therapy for idiopathic short stature with delayed puberty
Background. Growth hormone therapy for idiopathic short stature (ISS) is a subject of debate, because of the heterogeneous endocrine profile in these children.
G.N. Rakhimova, K.N. Gilyazetdinov
doaj +1 more source
In preclinical studies growth hormone and its primary mediator IGF-1 have shown potential to increase muscle mass and strength. A single patient with spinal muscular atrophy reported benefit after compassionate use of growth hormone.
Schottmann, G. +22 more
core +1 more source
Twin arginine translocation system in secretory expression of recombinant human growth hormone
Recombinant protein production in E. coli has several advantages over other expression systems. Misfolding, inclusion body formation, and lack of eukaryotic post translational modification are the most disadvantages of this system. Exporting of correctly
Mohammad Reza Bagherinejad +5 more
doaj +1 more source
An investigation of the anabolic actions of biosynthetic human growth hormone after injury by burning [PDF]
Previous clinical trials in normal subjects and post-operative patients have shown that biosynthetic growth hormone preparations increase nitrogen retention. It has been suggested that their administration to injured patients may be beneficial.
Belcher, H. J. C. R.
core +1 more source
Long-term safety and efficacy of Omnitrope® in adults with growth hormone deficiency: Italian interim analysis of the PATRO Adults study [PDF]
To report the long-term effectiveness and safety of the recombinant human growth hormone Omnitrope(®), a somatropin biosimilar to Genotropin(®), in Italian patients with growth hormone deficiency (GHD) enrolled in the PATRO Adults ...
Profka, E. +43 more
core +2 more sources
Jason Foo,1 Mohamad Maghnie,2 Annamaria Colao,3 Ioanna Vlachaki,4 Giorgio Colombo5,61Global Health Economics, Mapi Group (An ICON plc Company), Houten, The Netherlands; 2Department of Pediatrics, IRCCS Istituto Giannina Gaslini Institute, University of ...
Foo J +4 more
doaj
Andreas M Pleil,1 Feyza Darendeliler,2 Helmuth G Dörr,3 Katherine Hutchinson,4 Hartmut A Wollmann5 1Pfizer Inc., San Diego, CA, USA; 2Istanbul Faculty of Medicine, Pediatric Endocrinology Unit, Capa, Istanbul, Turkey; 3Department of Pediatrics ...
Pleil AM +4 more
doaj
Improving selectivity and sensitivity of protein quantitation by LC-HR-MS/MS:Determination of somatropin in rat plasma [PDF]
AIM: Protein quantitation by digestion of a biological sample followed by LC-MS analysis of a signature peptide can be a challenge because of the high complexity of the digested matrix.
Bischoff, Rainer +7 more
core +1 more source
Paolo Beck-Peccoz,1 Charlotte Höybye,2 Suat Simsek,3 Günter Stalla,4 Robert D Murray,5 Altaher Esmael,6 Dragan Urosevic,7 Anca Boldea,6 Markus Zabransky6 1Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Cà Granda Ospedale Maggiore ...
Beck-Peccoz P +8 more
doaj
Therapy of CRPC is one of the most difficult problems in oncourology. Until now the optimal consequence of use of drugs in CRPC is not determined.Study objective: evaluation of effectiveness of sequential therapeutic schemes in progression of m-CRPC ...
S. V. Mishugin +3 more
doaj +1 more source

